Cerebral blood flow augmentation in patients with severe subarachnoid haemorrhage

  • P. G. Al-Rawi
  • D. Zygun
  • M. Y. Tseng
  • P. J. A. Hutchinson
  • B. F. Matta
  • P. J. Kirkpatrick
Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 95)

Summary

Following aneurysmal subarachnoid haemorrhage (SAH), cerebral blood flow (CBF) may be reduced, resulting in poor outcome due to cerebral ischaemia and subsequent stroke. Hypertonic saline (HS) is known to be effective in reducing intracranial pressure (ICP) [16]. We have previously shown a 20–50% increase in CBF in ischaemic regions after intravenous infusion of HS [17]. This study aims to determine the effect of HS on CBF augmentation, substrate delivery and metabolism.

Continuous monitoring of arterial blood pressure (ABP), ICP, cerebral perfusion pressure (CPP), brain tissue oxygen (PbO2), middle cerebral artery flow velocity (FV), and microdialysis was performed in 14 poor grade SAH patients. Patients were given an infusion of 23.5% HS, and quantified xenon computerised tomography scanning (XeCT) was carried out before and after the infusion in 9 patients.

The results showed a significant increase in ABP, CPP, FV and PbO2, and a significant decrease in ICP (p < 0.05). Nine patients showed a decrease in lactate-pyruvate ratio at 60 minutes following HS infusion.

These results show that HS safely and effectively augments CBF in patients with poor grade SAH and significantly improves cerebral oxygenation. An improvement in cerebral metabolic status in terms of lactate-pyruvate ratio is also associated with HS infusion.

Keywords

Subarachnoid haemorrhage hypertonic saline brain tissue oxygen microdialysis xenon computerised tomography cerebral blood flow 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hutchinson PJA, Seeley HM, Kirkpatrick PJ (1998) Factors implicated in deaths from subarachnoid haemorrhage: are they avoidable? Br J Neurosurg 12: 37–40PubMedCrossRefGoogle Scholar
  2. 2.
    Kett-White R, Hutchinson PJ, Al-Rawi PG, Gupta AK, O’Connell MT, Pickard JD, Kirkpatrick PJ (2002) Extracellular lactate/pyruvate and glutamate changes in patients during peroperative episodes of cerebral ischaemia. Acta Neurochir (Wien) 81: 363–365Google Scholar
  3. 3.
    Kett-White R, Hutchinson PJ, Al-Rawi PG, Gupta AK, Pickard JD, Kirkpatrick PJ (2002) Adverse cerebral events detected after subarachnoid haemorrhage using brain oxygen and microdialysis probes. Neurosurgery 50: 1213–1222PubMedCrossRefGoogle Scholar
  4. 4.
    Kett-White R, Hutchinson PJA, Al-Rawi PG, Czosnyka M, Gupta AK, Pickard JD, Kirkpatrick PJ (2002) Cerebral oxygen and microdialysis monitoring during aneurysm surgery: effects of blood pressure, csf drainage and temporary clipping on infarction. J Neurosurg 96: 1013–1019PubMedGoogle Scholar
  5. 5.
    Kiening KL, Unterberg AW, Bardt TF, Schneider G-H, Lanksch WR (1996) Monitoring of cerebral oxygenation in patients with severe head injuries: brain tissue PO2 versus jugular vein oxygen saturation. J Neurosurg 85: 7–13Google Scholar
  6. 6.
    Kirkpatrick PJ, Smielewski P, Piechnik S, Pickard JD, Czosnyka M (1996) Early effects of mannitol in patients with head injuries assessed using bedside multimodality monitoring. Neurosurgery 39: 714–721PubMedCrossRefGoogle Scholar
  7. 7.
    Persson L, Valtysson J, Enblad P, Wärme P-E, Cesarini K, Lewén A, Hillered L (1996) Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 74: 606–616Google Scholar
  8. 8.
    Qureshi AI, Wilson DA, Traystman RJ (2002) Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism. J Neurosug Anaesthesiol 1: 22–30CrossRefGoogle Scholar
  9. 9.
    Ross N, Hutchinson PJ, Seeley H, Kirkpatrick PJ (2002) Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study. J Neurol Neurosurg Psychiatry 72: 480–484PubMedGoogle Scholar
  10. 10.
    Sarrafzadeh AS, Kiening KL, Callsen T-A, Unterberg AW (2003) Metabolic changes during impending and manifest cerebral hypoxia in traumatic brain injury. Br J Neurosurg 17: 340–346PubMedCrossRefGoogle Scholar
  11. 11.
    Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch WR, Unterberg AW (2002) Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid haemorrhage patients? Crit Care Med 30: 1070Google Scholar
  12. 12.
    Sarrafzadeh AS, Haux D, Sakowitz O, Benndorf G, Herzog H, Kuechler I, Unterberg A (2003) Acute focal neurological deficits in aneurysmal subarachnoid haemorrhage. Relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 34: 1382–1388PubMedCrossRefGoogle Scholar
  13. 13.
    Schultz MK, Wang LP, Tange M, et al (2000) Cerebral microdialysis monitoring: determination of normal and ischaemic cerebral metabolisms in patients with subarachnoid haemorrhage. J Neurosurg 93: 808–814CrossRefGoogle Scholar
  14. 14.
    Schwarz S, Georgiadis D, Aschoff A, Schwab S (2002) Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 33: 136–140PubMedCrossRefGoogle Scholar
  15. 15.
    Shackford SR, Zhuang J, Schmoker J (1992) Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg 76: 91–98PubMedGoogle Scholar
  16. 16.
    Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Schnitzer MS, Mirski M, Hanley DF, Ulatowski JA (1998) Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 26: 1118–1122PubMedCrossRefGoogle Scholar
  17. 17.
    Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ (2003) Effect of hypertonic saline on cerebral blood flow in poor grade patients with subarachnoid haemorrhage. Stroke 34: 1389–1397PubMedCrossRefGoogle Scholar
  18. 18.
    Yonas H, Sekhar L, Johnson DW, Gur D (1989) Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. Neurosurgery 24: 368–372PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • P. G. Al-Rawi
    • 2
  • D. Zygun
    • 3
    • 4
  • M. Y. Tseng
    • 2
  • P. J. A. Hutchinson
    • 2
  • B. F. Matta
    • 3
  • P. J. Kirkpatrick
    • 2
  1. 1.University Department of NeurosurgeryLevel 4, A-Block, Addenbrooke’s HospitalCambridgeUK
  2. 2.University Department of NeurosurgeryAddenbrooke’s HospitalCambridgeUK
  3. 3.University Department of AnaesthesiaAddenbrooke’s HospitalCambridgeUK
  4. 4.Department of Critical Care MedicineUniversity of CalgaryCalgaryCanada

Personalised recommendations